CSTL

32.8601.63%
TW

Tobin W. Juvenal

Chief Commercial Officer

Mr. Tobin W. Juvenal, also known as Toby, has been Chief Commercial Officer at Castle Biosciences, Inc. since August 2020. He served as Senior Vice President of Sales at Castle Biosciences Incorporated since January 2018 until August 2020 and served as Vice President of Sales since October 2008. Mr. Juvenal served as Vice President of US Sales and Marketing at Castle Biosciences Incorporated. Mr. Juvenal served as a Vice President of Sales of Encysive Pharmaceuticals Inc. from March 2005 to 2007. From 2001 to 2004, he was at Genzyme Corporation where he rose from Regional Business Director, through Specialty Accounts and into the leadership position of Vice President, Sales for the Renal Division in 2003 where he was responsible for a 200 person field and headquarters based group that included sales, managed markets, trade relations, account management, government accounts, and reimbursement. Mr. Juvenal has also held management positions at deCODE Genetics. Mr. Juvenal with over 20 years of sales and marketing experience, joined Encysive to build its U.S. sales force for the launch of Thelin. Mr. Juvenal served as Vice President of U.S. Sales for Genzyme Therapeutics where he was responsible for the recruitment and management of a 120 person sales team. Prior to Genzyme, Mr. Juvenal served as Regional Business Director and Area Sales Manager at Genetics Institute, Inc. He has also served as a Director of Disease Management Consulting for a division of Zeneca Pharmaceuticals and as District Sales Manager of Zeneca Oncology. He spent five years at Genetics Institute / Wyeth Oncology. He started his career in sales and sales management in the pharmaceutical industry with Stuart, now AstraZeneca. He serves as principal member of Stuart Disease Management Services (SDMS). Mr. Juvenal holds a Bachelor of Science in Marketing from the University of Florida.

公司职务